Tissue-Based Genomic Profiling Market

Tissue-Based Genomic Profiling: Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033

A recent market study published by FMI on Tissue-Based Genomic Profiling offers a global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Technology:

• Tumor tissue and Liquid DNA profiling
• Sequencing Techniques
• Immunohistochemistry
• Others

By Application:

• Personalized Medicine
• Oncological Diagnostics
• Research

By End User:

• Research Institutes
• Clinical Research Organizations
• Hospitals & Clinics
• Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East & Africa

Report Chapters

Executive Summary

The executive summary of the Tissue-Based Genomic Profiling includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Tissue-Based Genomic Profiling.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the Tissue-Based Genomic Profiling in this chapter, which will help to understand basic information about Tissue-Based Genomic Profiling. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Tissue-Based Genomic Profiling report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Technology processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global Tissue-Based Genomic Profiling Demand Analysis 2018-2022 and Forecast, 2023-2033

The chapter include historical market value (xx) analysis (2018-2022) and current and future market value (USD 2.2 billion) and volume (6.6%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global Tissue-Based Genomic Profiling - Pricing Analysis

Based on By Technology, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global Tissue-Based Genomic Profiling Analysis 2018-2022 and Forecast 2023-2033, By Technology

Based on By Technology, Tissue-Based Genomic Profiling is segmented into Tumor tissue and Liquid DNA profiling, Sequencing Techniques, Immunohistochemistry, Others. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Technology.

Chapter 06 - Global Tissue-Based Genomic Profiling Analysis 2018-2022 and Forecast 2023-2033, By Application

Based on By Application, Tissue-Based Genomic Profiling is segmented into Personalized Medicine, Oncological Diagnostics, Research. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Application.

Chapter 07 - Global Tissue-Based Genomic Profiling Analysis 2018-2022 and Forecast 2023-2033, By End User

Based on By End User, Tissue-Based Genomic Profiling is segmented into Research Institutes, Clinical Research Organizations, Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Others. This section also offers market attractiveness analysis based on By End User. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By End User.

Chapter 08 - Tissue-Based Genomic Profiling Analysis 2018-2022 and Forecast 2023-2033, By Region

Based on By Region, Tissue-Based Genomic Profiling is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 09 - North America Tissue-Based Genomic Profiling Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of the Tissue-Based Genomic Profiling in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.

Chapter 10 - Latin America Tissue-Based Genomic Profiling Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Tissue-Based Genomic Profiling in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Tissue-Based Genomic Profiling in the Latin America region.

Chapter 11 - Europe Tissue-Based Genomic Profiling Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Tissue-Based Genomic Profiling in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Tissue-Based Genomic Profiling in the regional market.

Chapter 12 - East Asia Tissue-Based Genomic Profiling Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Tissue-Based Genomic Profiling in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Tissue-Based Genomic Profiling in the regional market.

Chapter 13 - South Asia Tissue-Based Genomic Profiling Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Tissue-Based Genomic Profiling in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Tissue-Based Genomic Profiling in the regional market.

Chapter 14 - Middle East and Africa Tissue-Based Genomic Profiling Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Tissue-Based Genomic Profiling in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Tissue-Based Genomic Profiling in the regional market.

Chapter 15 - Key Countries Tissue-Based Genomic Profiling Analysis 2018-2022 and Forecast 2023-2033

This chapter offers insights into how the Tissue-Based Genomic Profiling is expected to grow in major countries globally.

Chapter 16 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 17 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Technology portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are FOUNDATION MEDICINE, INC., Laboratory Corporation of America Holdings (Personal Genome Diagnostics Inc. (PGDx) ), Illumina, Inc., QIAGEN, Roche Diagnostics, Thermo Fisher Scientific., Exact Science

Chapter 18 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Tissue-Based Genomic Profiling report.

Chapter 19 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Tissue-Based Genomic Profiling.